RUBICONUpdated 1 Sept 2026, 15:26

Rubicon Research Limited

RUBICONUpdated 1 Sept 2026, 15:26

Market Cap

₹30,175Cr.

Current Price

₹1,823

High / Low

₹1,899/571

Stock P/E

128

ROE18.7%

ROCE21.0%

Book Value₹82.0

Face Value₹1.00

Dividend Yield0.08%

About

Incorporated in 1999, Rubicon Research Limited is a pharmaceutical company engaged in the development, manufacturing, & commercialization of differentiated formulations.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	194	169	213	209	146	170	199
Inventory Days	360	373	203	609	309	305	365
Days Payable	213	212	206	353	167	218	275
Cash Conversion Cycle	341	330	210	465	288	258	290
Working Capital Days	191	168	159	75	53	110	197
ROCE %	—	21%	5%	1%	9%	26%	21%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 15:26

RUBICON RESEARCH LIMITED (RUBICON) financials — quarterly results, P&L, cash flow, balance sheet, shareholding